A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia

  • Hartmut Döhner
  • Carsten Müller-Tidow
  • Michael Lübbert
  • Walter Fiedler
  • Alwin Krämer
  • Jörg Westermann
  • Gesine Bug
  • Richard F Schlenk
  • Utz Krug
  • Rainer-Georg Goeldner
  • James Hilbert
  • Tillmann Taube
  • Oliver G Ottmann

Related Research units

Bibliographical data

Original languageEnglish
ISSN0007-1048
DOIs
Publication statusPublished - 05.2019
PubMed 30450591